Rockefeller Capital Management
GMAB icon

Rockefeller Capital Management’s Genmab GMAB Stock Holding History

Rockefeller Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$431K Buy
16,073
+3,501
+28% +$105K ﹤0.01% 2060
2025
Q4 		$387K Buy
12,572
+10,376
+472% +$323K ﹤0.01% 2036
2025
Q3 		$67.4K Sell
2,196
-10,735
-83% -$262K ﹤0.01% 2767
2025
Q2 		$267K Buy
+12,931
New +$265K ﹤0.01% 1674
2025
Q1 		– Sell
-14,894
Closed -$316K – 1692
2024
Q4 		$316K Sell
14,894
-1,280
-8% -$28.1K ﹤0.01% 1589
2024
Q3 		$397K Sell
16,174
-871
-5% -$23.3K ﹤0.01% 1497
2024
Q2 		$431K Sell
17,045
-4,450
-21% -$126K ﹤0.01% 1483
2024
Q1 		$643K Buy
21,495
+3,224
+18% +$94.7K ﹤0.01% 1394
2023
Q4 		$582K Sell
18,271
-648
-3% -$20.3K ﹤0.01% 1307
2023
Q3 		$667K Buy
18,919
+4,945
+35% +$188K ﹤0.01% 1223
2023
Q2 		$531K Sell
13,974
-4,534
-24% -$181K ﹤0.01% 1317
2023
Q1 		$698K Buy
18,508
+310
+2% +$11.9K ﹤0.01% 1207
2022
Q4 		$770K Buy
18,198
+4,009
+28% +$165K ﹤0.01% 1102
2022
Q3 		$454K Buy
14,189
+904
+7% +$31.7K ﹤0.01% 1306
2022
Q2 		$430K Sell
13,285
-5
-0% -$162 ﹤0.01% 1328
2022
Q1 		$480K Sell
13,290
-53
-0.4% -$1.82K ﹤0.01% 1326
2021
Q4 		$527K Sell
13,343
-308
-2% -$12.8K ﹤0.01% 1292
2021
Q3 		$596K Buy
13,651
+2,493
+22% +$112K ﹤0.01% 1195
2021
Q2 		$455K Sell
11,158
-1,978
-15% -$76.3K ﹤0.01% 1228
2021
Q1 		$430K Buy
13,136
+3,176
+32% +$119K ﹤0.01% 1072
2020
Q4 		$404K Buy
9,960
+6,858
+221% +$256K ﹤0.01% 984
2020
Q3 		$112K Buy
3,102
+424
+16% +$15.3K ﹤0.01% 1214
2020
Q2 		$91K Buy
2,678
+1,871
+232% +$51K ﹤0.01% 1196
2020
Q1 		$17K Buy
807
+432
+115% +$9.63K ﹤0.01% 1563
2019
Q4 		$8K Sell
375
-282
-43% -$6.15K ﹤0.01% 1665
2019
Q3 		$13K Buy
+657
New +$12.9K ﹤0.01% 1344

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Rockefeller Capital Management's GMAB Position: Q1 2026 in Review

Rockefeller Capital Management increased its Genmab (GMAB) stake by 28% in Q1 2026, buying an estimated $105K and bringing the position to 16,073 shares worth $431K. The position accounts for ﹤0.01% of the portfolio, ranked #2060.

Rockefeller Capital Management first reported a position in GMAB in Q3 2019 and has held it in 26 quarters since. The position peaked at $770K in Q4 2022. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Rockefeller Capital Management held 16,073 shares of Genmab worth $431K as of Q1 2026.
  • Rockefeller Capital Management bought 3,501 Genmab shares in Q1 2026, an estimated $105K.
  • Genmab made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #2060 holding.
  • Rockefeller Capital Management first reported a position in Genmab in Q3 2019 and has held it in 26 quarters since.
  • Rockefeller Capital Management's Genmab position peaked at $770K in Q4 2022.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.